Gabriela Zofia Prus
Blegdamsvej 3, 2200 København N.
Gabriela studied biotechnology at the Jagiellonian University, Krakow, Poland. There, she began her adventure with mass spectrometry-based proteomics technologies. She gained experience during internships at MaxPlanck Institute for Biochemistry in Martinsried, Germany and Karolinska University, Stockholm, Sweden. During her Master studies she investigated the antipsychotic drug molecular mechanism of action. In 2017 she was accepted into the CPH Bioscience PhD Programme and joined Chuna Choudhary’s lab. Currently Gabriela is interested in DUB-regulated ubiquitylation signaling